// AST – IMS - [DMinute_ROS]

Biogen (BIIB) Holding Boosted by American Century Companies Inc; 3M Company (MMM) Valuation Declined While Jarislowsky Fraser LTD Has Trimmed Its Stake

3M Company (NYSE:MMM) Logo

American Century Companies Inc increased its stake in Biogen Inc (BIIB) by 32.09% based on its latest 2018Q3 regulatory filing with the SEC. American Century Companies Inc bought 366,361 shares as the company’s stock declined 6.12% with the market. The institutional investor held 1.51 million shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $532.75M, up from 1.14 million at the end of the previous reported quarter. American Century Companies Inc who had been investing in Biogen Inc for a number of months, seems to be bullish on the $66.73B market cap company. The stock increased 1.40% or $4.56 during the last trading session, reaching $331.19. About 845,819 shares traded. Biogen Inc. (NASDAQ:BIIB) has declined 0.04% since January 11, 2018 and is downtrending. It has underperformed by 0.04% the S&P500. Some Historical BIIB News: 24/04/2018 – Biogen Idec 1Q Net $1.2B; 20/04/2018 – BIOGEN – CO, IONIS EXPANDED COLLABORATION THROUGH NEW 10-YR AGREEMENT TO DEVELOP NOVEL ANTISENSE DRUG CANDIDATES FOR RANGE OF NEUROLOGICAL DISEASES; 20/04/2018 – BIOGEN INC – IN COLLABORATION, IONIS WILL BE RESPONSIBLE FOR IDENTIFICATION OF ANTISENSE DRUG CANDIDATES BASED ON SELECTED TARGETS; 01/05/2018 – Biogen Licensed Worldwide Rights to Aducanumab From Neurimmune in 2007; 01/05/2018 – BIIB TO MAKE 1-TIME $50M PAYMENT TO NEURIMMUNE FOR 5% REDUCTION; 27/04/2018 – Biogen Closes Above 50-Day Moving Average: Technicals; 01/05/2018 – Biogen Gets 5% Reduction in Original Royalty Rates on Potential Commercial Sales of Aducanumab; 05/04/2018 – Biogen, Samsung Bioepis to Make Royalty Payments to AbbVie; 15/05/2018 – Bridgewater Adds Biogen, Exits Costco, Buys More Newfield: 13F; 11/04/2018 – STAT Plus: Biogen and the badly needed gene therapy acquisition that got away

Jarislowsky Fraser Ltd decreased its stake in 3M Company (MMM) by 0.67% based on its latest 2018Q3 regulatory filing with the SEC. Jarislowsky Fraser Ltd sold 5,037 shares as the company’s stock declined 6.86% with the market. The institutional investor held 745,112 shares of the medical and dental instruments company at the end of 2018Q3, valued at $141.77 million, down from 750,149 at the end of the previous reported quarter. Jarislowsky Fraser Ltd who had been investing in 3M Company for a number of months, seems to be less bullish one the $112.73B market cap company. The stock increased 0.68% or $1.3 during the last trading session, reaching $193.6. About 1.94 million shares traded. 3M Company (NYSE:MMM) has declined 17.47% since January 11, 2018 and is downtrending. It has underperformed by 17.47% the S&P500. Some Historical MMM News: 09/05/2018 – LifeSignals Launches Life Signal(TM) Processor Product Family, Developed with Support of 3M and STMicroelectronics; 24/04/2018 – 3M Now Sees 2018 Organic Local-Currency Sales Growth 3%-4%; 21/05/2018 – 3M FORMS SUSTAINABILITY-PRODUCT STEWARDSHIP ORGANIZATION; 08/05/2018 – 3M Board Declares Quarterly Dividend; 08/03/2018 – FASTPARTNER AB – LOAN RUNS WITH VARIABLE INTEREST RATE OF STIBOR 3M + 2.45 PERCENTAGE POINTS WITH MATURITY IN SEPTEMBER 2021; 25/05/2018 – Hartford Value HLS Adds US Foods Holding, Exits 3M Co; 03/05/2018 – 3M’s New Single-Patient Stethoscope Fills lmmense Auscultation Quality Gap for Clinicians Treating Patients in lsolation; 24/04/2018 – 3M CO MMM.N SEES FY 2018 ADJUSTED SHR $10.20 TO $10.55 EXCLUDING ITEMS; 08/05/2018 – 3M CO – SHAREHOLDERS ELECTED THE 12 DIRECTOR NOMINEES TO COMPANY’S BOARD OF DIRECTORS FOR A ONE-YEAR TERM; 13/03/2018 – Communicating In Tough Conditions Just Got Easier With New Post-it Extreme Notes

American Century Companies Inc, which manages about $102.56 billion US Long portfolio, decreased its stake in Catalent Inc (NYSE:CTLT) by 2.80 million shares to 253,358 shares, valued at $11.54 million in 2018Q3, according to the filing. It also reduced its holding in Ishares Tr (IWF) by 327,222 shares in the quarter, leaving it with 204,656 shares, and cut its stake in Webster Finl Corp Conn (NYSE:WBS).

Investors sentiment decreased to 1.01 in Q3 2018. Its down 0.01, from 1.02 in 2018Q2. It is negative, as 45 investors sold BIIB shares while 334 reduced holdings. 138 funds opened positions while 243 raised stakes. 167.21 million shares or 1.69% less from 170.10 million shares in 2018Q2 were reported. North Star Asset Mgmt Incorporated owns 1,897 shares for 0.05% of their portfolio. Mirae Asset Glob Investments Limited holds 27,536 shares or 0.07% of its portfolio. Edgemoor Advsrs Inc owns 900 shares. Guernsey-based Bluecrest Capital Limited has invested 0.2% in Biogen Inc. (NASDAQ:BIIB). Kornitzer Capital Inc Ks, Kansas-based fund reported 15,017 shares. Cibc Asset Mgmt reported 0.06% in Biogen Inc. (NASDAQ:BIIB). Maryland-based Clearbridge Lc has invested 0.78% in Biogen Inc. (NASDAQ:BIIB). Indexiq Advsr Ltd Co reported 16,289 shares or 0.19% of all its holdings. Montag & Caldwell Ltd Liability Corp holds 1,100 shares. Bowling Portfolio Mngmt Limited Liability reported 3,995 shares stake. Atalanta Sosnoff Cap Limited Liability Company accumulated 0.03% or 2,400 shares. Pinebridge Limited Partnership has 0.41% invested in Biogen Inc. (NASDAQ:BIIB) for 61,843 shares. Mitsubishi Ufj Tru And Banking Corporation, a Japan-based fund reported 178,116 shares. Meritage Port, Kansas-based fund reported 17,567 shares. Horan Capital Mgmt reported 497 shares stake.

Among 35 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 27 have Buy rating, 0 Sell and 8 Hold. Therefore 77% are positive. Biogen Idec Inc. had 147 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Buy” rating by Stifel Nicolaus on Tuesday, April 24. On Thursday, December 29 the stock rating was maintained by Raymond James with “Strong Buy”. Canaccord Genuity upgraded the shares of BIIB in report on Thursday, May 31 to “Buy” rating. The firm has “Hold” rating given on Tuesday, July 25 by Cantor Fitzgerald. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, October 17. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Buy” rating by Standpoint Research on Thursday, January 7. The stock has “Buy” rating by H.C. Wainwright on Tuesday, August 11. Bernstein maintained the shares of BIIB in report on Tuesday, November 28 with “Buy” rating. The firm has “Buy” rating by Cowen & Co given on Thursday, January 25. Wells Fargo maintained the stock with “Outperform” rating in Friday, December 4 report.

Since September 26, 2018, it had 0 insider buys, and 1 sale for $350,000 activity.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Seekingalpha.com which released: “EMA grants Prime status for Roche’s risdiplam for SMA – Seeking Alpha” on December 17, 2018, also Nasdaq.com with their article: “Noteworthy Tuesday Option Activity: BA, BIIB, BHF – Nasdaq” published on December 18, 2018, Nasdaq.com published: “Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions – Nasdaq” on January 04, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Seekingalpha.com and their article: “Biogen down 5%, sell-siders soften outlook – Seeking Alpha” published on December 18, 2018 as well as Nasdaq.com‘s news article titled: “Alkermes and Biogen Announce Submission of a New Drug Application to US Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis – Nasdaq” with publication date: December 17, 2018.

Analysts await 3M Company (NYSE:MMM) to report earnings on January, 29 before the open. They expect $2.28 earnings per share, up 8.57% or $0.18 from last year’s $2.1 per share. MMM’s profit will be $1.33 billion for 21.23 P/E if the $2.28 EPS becomes a reality. After $2.58 actual earnings per share reported by 3M Company for the previous quarter, Wall Street now forecasts -11.63% negative EPS growth.

More important recent 3M Company (NYSE:MMM) news were published by: Seekingalpha.com which released: “How Safe Is 3M’s Dividend? – Seeking Alpha” on January 04, 2019, also Seekingalpha.com published article titled: “3M discontinues production of MEAs – Seeking Alpha”, Seekingalpha.com published: “3M: Should Investors Worry About Rising Debt Levels? – Seeking Alpha” on December 17, 2018. More interesting news about 3M Company (NYSE:MMM) was released by: Seekingalpha.com and their article: “3M to buy M*Modal’s tech business for $1.0B enterprise value – Seeking Alpha” with publication date: December 19, 2018.

Investors sentiment increased to 1.03 in Q3 2018. Its up 0.06, from 0.97 in 2018Q2. It improved, as 47 investors sold MMM shares while 535 reduced holdings. 117 funds opened positions while 480 raised stakes. 371.40 million shares or 0.76% less from 374.25 million shares in 2018Q2 were reported. Ami Asset Mgmt holds 1.37% in 3M Company (NYSE:MMM) or 95,545 shares. 1,479 were accumulated by Ntv Asset Ltd Limited Liability Company. Private Na owns 20,160 shares for 0.87% of their portfolio. 80,985 were accumulated by Argent Trust. Anchor Capital Advsr Llc owns 86,694 shares. Cleararc Capital invested in 0.44% or 15,854 shares. Mitchell Mcleod Pugh & Williams reported 1,974 shares. Wheatland Inc reported 2.43% in 3M Company (NYSE:MMM). Wilbanks Smith Thomas Asset Lc invested in 0.06% or 4,628 shares. Penobscot Mngmt owns 35,473 shares or 1.62% of their US portfolio. Bangor Bancorporation holds 0.07% or 1,882 shares in its portfolio. Burke Herbert Bancorp Trust Company has invested 1.08% in 3M Company (NYSE:MMM). Crestwood Advisors Limited Com, Massachusetts-based fund reported 87,122 shares. Moon Limited reported 0% stake. The New Jersey-based Regentatlantic Capital Limited Liability Company has invested 0.11% in 3M Company (NYSE:MMM).

Since September 10, 2018, it had 1 buying transaction, and 1 sale for $90,252 activity. Shares for $274,752 were sold by Hammes Eric D. on Monday, September 10.

Among 17 analysts covering 3M (NYSE:MMM), 7 have Buy rating, 3 Sell and 7 Hold. Therefore 41% are positive. 3M had 107 analyst reports since July 24, 2015 according to SRatingsIntel. J.P. Morgan maintained the stock with “Sell” rating in Thursday, January 18 report. The company was maintained on Monday, August 14 by Jefferies. The company was initiated on Thursday, January 21 by Citigroup. The firm has “Underweight” rating by JP Morgan given on Thursday, April 26. Deutsche Bank maintained the stock with “Hold” rating in Friday, November 16 report. The stock of 3M Company (NYSE:MMM) earned “Underperform” rating by RBC Capital Markets on Tuesday, August 4. The company was maintained on Wednesday, October 24 by Argus Research. The rating was downgraded by Jefferies on Wednesday, May 16 to “Hold”. RBC Capital Markets upgraded the stock to “Buy” rating in Thursday, May 3 report. The stock of 3M Company (NYSE:MMM) earned “Buy” rating by Bank of America on Tuesday, June 6.

Jarislowsky Fraser Ltd, which manages about $33.95 billion and $16.12B US Long portfolio, upped its stake in Mitsubishi Ufj Financial Group Adr (NYSE:MTU) by 50,460 shares to 452,247 shares, valued at $2.72M in 2018Q3, according to the filing. It also increased its holding in Alibaba Group Holding (NYSE:BABA) by 170,812 shares in the quarter, for a total of 212,938 shares, and has risen its stake in Banco Bradesco Adr (NYSE:BBD).

3M Company (NYSE:MMM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.